156 related articles for article (PubMed ID: 7490523)
1. Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription.
Finidori J; Kelly PA
J Endocrinol; 1995 Oct; 147(1):11-23. PubMed ID: 7490523
[No Abstract] [Full Text] [Related]
2. Jaks and Stats in signaling by the cytokine receptor superfamily.
Ihle JN; Kerr IM
Trends Genet; 1995 Feb; 11(2):69-74. PubMed ID: 7716810
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Jak/STAT signalling pathway.
Finbloom DS; Larner AC
Cell Signal; 1995 Nov; 7(8):739-45. PubMed ID: 8593242
[No Abstract] [Full Text] [Related]
4. The Janus protein tyrosine kinases in hematopoietic cytokine signaling.
Ihle JN
Semin Immunol; 1995 Aug; 7(4):247-54. PubMed ID: 8520029
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
6. Signaling by the cytokine receptor superfamily: JAKs and STATs.
Ihle JN; Witthuhn BA; Quelle FW; Yamamoto K; Thierfelder WE; Kreider B; Silvennoinen O
Trends Biochem Sci; 1994 May; 19(5):222-7. PubMed ID: 8048164
[TBL] [Abstract][Full Text] [Related]
7. Cytokine signal transduction and the JAK family of protein tyrosine kinases.
Wilks AF; Harpur AG
Bioessays; 1994 May; 16(5):313-20. PubMed ID: 8024540
[TBL] [Abstract][Full Text] [Related]
8. The Jak-Stat pathway in normal and perturbed hematopoiesis.
Ward AC; Touw I; Yoshimura A
Blood; 2000 Jan; 95(1):19-29. PubMed ID: 10607680
[No Abstract] [Full Text] [Related]
9. [Cytokine signaling].
Chida D; Miyajima A
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1525-31. PubMed ID: 9279077
[No Abstract] [Full Text] [Related]
10. [Advances in basic research on Janus kinase/signal transducer and activators of transcription pathway and sepsis].
Wang SB; Yao YM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Nov; 15(11):690-3. PubMed ID: 14604492
[No Abstract] [Full Text] [Related]
11. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
Nosaka T; Kitamura T
Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
[TBL] [Abstract][Full Text] [Related]
12. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction by interleukin-12 and interleukin-2. A comparison and contrast.
Bacon CM; Cho SS; O'Shea JJ
Ann N Y Acad Sci; 1996 Oct; 795():41-59. PubMed ID: 8958916
[No Abstract] [Full Text] [Related]
14. [The JAK-STAT signaling pathway and its role in oncogenesis, immunomodulation and development].
Duarte RF; Frank DA
Med Clin (Barc); 2000 Feb; 114(6):227-34. PubMed ID: 10757107
[No Abstract] [Full Text] [Related]
15. Signaling by the cytokine receptor superfamily.
Ihle JN; Thierfelder W; Teglund S; Stravopodis D; Wang D; Feng J; Parganas E
Ann N Y Acad Sci; 1998 Dec; 865():1-9. PubMed ID: 9927991
[TBL] [Abstract][Full Text] [Related]
16. Cross-regulation of JAK and Src kinases.
Ingley E; Klinken SP
Growth Factors; 2006 Mar; 24(1):89-95. PubMed ID: 16393697
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
[TBL] [Abstract][Full Text] [Related]
18. Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kanwar VS; Witthuhn B; Campana D; Ihle JN
Blood; 1996 Jun; 87(11):4911-2. PubMed ID: 8639867
[No Abstract] [Full Text] [Related]
19. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
20. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
